Publication | Open Access
Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study
160
Citations
10
References
2022
Year
OS and QoL in GBM patients remains poor despite constant research and studies. Maximum safe resection followed by adjuvant temozolomide has shown improvement in OS. Post-surgery and adjuvant radiotherapy patients have shown a decrease in symptoms and better QoL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1